Search research articles
Contact Us
Filters
Showing results (1-10 of 427) with videos related to
Page
of 43
Sort By:
Seminars in Oncology
|
August 4, 2011
Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions
Jeffrey A Meyerhardt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2013
We are what we eat, or are we?
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
May 14, 2021
Determining the optimal duration of adjuvant therapy in colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
The impact of glycemic levels in patients with colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
February 18, 2011
Adjuvant therapy for stage II and III colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2016
What should we tell our patients with colorectal cancer about diet, supplements, and lifestyle?
Jeffrey A Meyerhardt
Hematology/Oncology Clinics of North America
|
May 3, 2022
Impact of Diet and Exercise on Colorectal Cancer
Seohyuk Lee, Jeffrey A Meyerhardt
JAMA Oncology
|
June 15, 2023
Assessment and Prognostic Value of Inflammatory Biomarkers in Patients With Colon Cancer-Reply
En Cheng, Jeffrey A Meyerhardt
Oncology (Williston Park, N.Y.)
|
June 13, 2003
Adjuvant therapy in gastric cancer: can we prevent recurrences?
Jeffrey A Meyerhardt, Charles S Fuchs
Seminars in Oncology
|
July 19, 2003
Follow-up strategies after curative resection of colorectal cancer
Jeffrey A Meyerhardt, Robert J Mayer
Page
of 43
Search research articles
Search
Showing results (1-10 of 427) with videos related to
Sort By:
Page
of 43
Seminars in Oncology
|
August 4, 2011
Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions
Jeffrey A Meyerhardt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2013
We are what we eat, or are we?
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
May 14, 2021
Determining the optimal duration of adjuvant therapy in colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
The impact of glycemic levels in patients with colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
February 18, 2011
Adjuvant therapy for stage II and III colon cancer
Jeffrey A Meyerhardt
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2016
What should we tell our patients with colorectal cancer about diet, supplements, and lifestyle?
Jeffrey A Meyerhardt
Hematology/Oncology Clinics of North America
|
May 3, 2022
Impact of Diet and Exercise on Colorectal Cancer
Seohyuk Lee, Jeffrey A Meyerhardt
JAMA Oncology
|
June 15, 2023
Assessment and Prognostic Value of Inflammatory Biomarkers in Patients With Colon Cancer-Reply
En Cheng, Jeffrey A Meyerhardt
Oncology (Williston Park, N.Y.)
|
June 13, 2003
Adjuvant therapy in gastric cancer: can we prevent recurrences?
Jeffrey A Meyerhardt, Charles S Fuchs
Seminars in Oncology
|
July 19, 2003
Follow-up strategies after curative resection of colorectal cancer
Jeffrey A Meyerhardt, Robert J Mayer
Page
of 43